Prostate Cancer - Results from #21180

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer - Abstract February 25, 2014

Metastatic castration-resistant prostate cancer. Part 2: Helping patients make informed choices and managing treatment side effects - Abstract February 25, 2014

Interfraction prostate movement in bone alignment after rectal enema for radiotherapy - Abstract February 24, 2014

The fluctuation of PCA3 score in men undergoing first or repeat prostate biopsies - Abstract February 24, 2014

Therapeutic modulation of prostate cancer metastasis - Abstract February 24, 2014

Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: Estimations of the number needed to treat based on competing-risks analysis - Abstract February 24, 2014

Can supervised exercise prevent treatment toxicity in prostate cancer patients initiating androgen deprivation therapy: A randomised controlled trial - Abstract February 24, 2014

The role of magnetic resonance imaging in delineating clinically significant prostate cancer - Abstract February 24, 2014

The association of tumor volume with mortality following radical prostatectomy - Abstract February 24, 2014

The accuracy of prostate cancer localization diagnosed on transrectal ultrasound-guided biopsy compared to 3-dimensional transperineal approach - Abstract February 24, 2014

Prostate imaging: Evaluation of a reusable two-channel endorectal receiver coil for MR imaging at 1.5 T - Abstract February 24, 2014

Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer - Abstract February 22, 2014

Metastatic castration-resistant prostate cancer. Part 1: The challenges of the disease and its treatment - Abstract February 22, 2014

Real-time elastography for the detection of prostate cancer - Abstract February 22, 2014

Quantitative EMG of external urethral sphincter in neurologically healthy men with prostate pathology - Abstract February 22, 2014

A method to estimate composite doses for organs at risk in prostate cancer patients treated with EBRT in combination with HDR BT - Abstract February 22, 2014

Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: A systematic review and meta-analysis - Abstract February 22, 2014

Surgical quality is more than volume: The association between changing urologists and complications for patients with localized prostate cancer - Abstract February 22, 2014

Statins: Protectors or pretenders in prostate cancer? - Abstract February 22, 2014

Dietary lycopene, angiogenesis, and prostate cancer: A prospective study in the prostate-specific antigen era - Abstract February 22, 2014

Page 1060 of 1437